The American College of Allergy, Asthma, and Immunology Registry For Allergic, Asthmatic Pregnant Patients (RAAPP)

Lipkowitz, Myron A.

doi:10.1016/s0091-6749(99)70266-6

Cited by 8 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A multidrug pregnancy exposure registry actively collects information on exposure to various drug therapies in specific diseases, such as human immunodeficiency virus (HIV) (White et al, 1997), epilepsy (The North American Pregnancy and Epilepsy Registry 1998), or asthma (Lipkowitz 1999;Scialli 1999). In some cases, a general multidrug registry, such as that conducted by a teratogen information service, collects information on drugs for unrelated indications.…”

Section: Multidrug Pregnancy Exposure Registriesmentioning

confidence: 99%

Food and Drug Administration

Lindborg¹,

Ellenberg²

2012

Encyclopedia of Biopharmaceutical Statistics, Third Edition

View full text Add to dashboard Cite

Section: Multidrug Pregnancy Exposure Registriesmentioning

confidence: 99%

Food and Drug Administration

Lindborg¹,

Ellenberg²

2012

Encyclopedia of Biopharmaceutical Statistics, Third Edition

View full text Add to dashboard Cite

Section: Multidrug Pregnancy Exposure Registriesmentioning

confidence: 99%

The Food and Drug Administration

Jaffee¹

2000

Archives of Facial Plastic Surgery

View full text Add to dashboard Cite

Asthma in pregnancy

Tan

Thomson

2000

The American Journal of Medicine

View full text Add to dashboard Cite

Although about 1% of pregnant women have asthma, it is often underrecognized and suboptimally treated. The course of asthma during pregnancy varies; it improves, remains stable, or worsens in similar proportions of women. The risk of an asthma exacerbation is high immediately postpartum, but the severity of asthma usually returns to the preconception level after delivery and often follows a similar course during subsequent pregnancies. Changes in beta(2)-adrenoceptor responsiveness and changes in airway inflammation induced by high levels of circulating progesterone have been proposed as possible explanations for the effects of pregnancy on asthma. Good control of asthma is essential for maternal and fetal well-being. Acute asthmatic attacks can result in dangerously low fetal oxygenation. Chronically poor control is associated with pregnancy-induced hypertension, preeclampsia, and uterine hemorrhage, as well as greater rates of cesarian section, preterm delivery, intrauterine growth retardation, low birth weight, and congenital malformation. Women with well-controlled asthma during pregnancy, however, have outcomes as good as those in their nonasthmatic counterparts. Inhaled therapies remain the cornerstone of treatment; most appear to be safe in pregnancy.

show abstract

The American College of Allergy, Asthma, and Immunology Registry For Allergic, Asthmatic Pregnant Patients (RAAPP)

Cited by 8 publications

References 0 publications

Food and Drug Administration

Food and Drug Administration

The Food and Drug Administration

Asthma in pregnancy

Contact Info

Product

Resources

About